⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 21, 2021The Lancet Infectious DiseasesOpen Access

Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

View Full Paper

Ask AI

Bookmark

Share

Abstract

Gavi, The Vaccine Alliance; Bill & Melinda Gates Foundation; UK Medical Research Council; Pfizer Ltd.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mackenzie et al. (2021) studied this question.

synapsesocial.com/papers/69d73b8e3f2a6ac123b8ab5e https://doi.org/10.1016/s1473-3099(20)30880-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15Original Research · 2018 · 1,124 citations
2Effects of Vaccination on Invasive Pneumococcal Disease in South AfricaOriginal Research · 2014 · 378 citations
3Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance studyCross-Sectional Study · 2019 · 172 citations
4Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance studyOriginal Research · 2016 · 182 citations
5Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studiesCase-Control Study · 2017 · 100 citations